Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 2012International Journal of Clinical PracticeOpen Access

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRiccardo LencioniUniversity of Pisa
Masatoshi Kudo
Masatoshi KudoKanazawa UniversitySYS.-L. YeFudan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lencioni et al. (2012) studied this question.

synapsesocial.com/papers/69d7ebb63b601d7be3ae348ahttps://doi.org/10.1111/j.1742-1241.2012.02940.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase 2 open‐label study of single‐agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B–endemic Asian population2008 · 143 citations
  2. 2Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials2006 · 345 citations
  3. 3Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma2006 · 1,205 citations
  4. 4Local-Regional Treatment of Hepatocellular Carcinoma2011 · 514 citations
  5. 5The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective2010 · 979 citations